179 related articles for article (PubMed ID: 26459257)
1. Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?
Park HJ; Kim K; Paik JH; Chie EK; Kim S; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2016 Jun; 18(6):625-31. PubMed ID: 26459257
[TBL] [Abstract][Full Text] [Related]
2. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.
Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
World J Gastroenterol; 2013 Mar; 19(9):1438-43. PubMed ID: 23539485
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer.
Kim BH; Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
Am J Clin Oncol; 2017 Apr; 40(2):158-162. PubMed ID: 25171299
[TBL] [Abstract][Full Text] [Related]
5. High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients.
Park Y; Kim K; Paik JH; Chie EK; Jang JY; Kim SW; Oh DY
Eur J Surg Oncol; 2018 May; 44(5):638-643. PubMed ID: 29422250
[TBL] [Abstract][Full Text] [Related]
6. High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy.
Lim YJ; Koh J; Kim K; Chie EK; Kim B; Lee KB; Jang JY; Kim SW; Oh DY; Bang YJ; Ha SW
Radiother Oncol; 2015 Oct; 117(1):165-70. PubMed ID: 26235847
[TBL] [Abstract][Full Text] [Related]
7. Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):81-7. PubMed ID: 22789492
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.
Kim BH; Kim K; Chie EK; Kwon J; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
J Gastrointest Surg; 2015 Oct; 19(10):1833-41. PubMed ID: 26239516
[TBL] [Abstract][Full Text] [Related]
9. Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy.
Song C; Kim K; Chie EK; Kim JH; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):499-504. PubMed ID: 24074923
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14).
Kim K; Yu JI; Jung W; Kim TH; Seong J; Kim WC; Choi JH; Park Y; Jeong BK; Kim BH; Kim TG; Kim JH; Park HJ; Shin HS; Im JH; Heo JS; Park JO; Jang JY; Oh DY; Woo SM; Lee WJ; Chie EK
Eur J Cancer; 2021 Nov; 157():31-39. PubMed ID: 34474218
[TBL] [Abstract][Full Text] [Related]
11. The Role of Adjuvant Chemoradiotherapy in Nonhilar Extrahepatic Bile Duct Cancer: A Long-Term Single-Institution Analysis.
Chang WI; Kim BH; Kang HC; Kim K; Lee KH; Oh DY; Kim H; Kwon W; Jang JY; Chie EK
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):395-404. PubMed ID: 34029643
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
Kim TH; Han SS; Park SJ; Lee WJ; Woo SM; Moon SH; Yoo T; Kim SS; Kim SH; Hong EK; Kim DY; Park JW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e853-9. PubMed ID: 21497455
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.
Itoh H; Nishijima K; Kurosaka Y; Takegawa S; Kiriyama M; Dohba S; Kojima Y; Saitoh Y
Dig Dis Sci; 2005 Dec; 50(12):2231-42. PubMed ID: 16416167
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
Park HJ; Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Anticancer Res; 2014 Nov; 34(11):6685-90. PubMed ID: 25368275
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin.
Han IW; Jang JY; Lee KB; Kang MJ; Kwon W; Park JW; Chang YR; Kim SW
HPB (Oxford); 2014 Jun; 16(6):575-81. PubMed ID: 24308425
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.
Komatsubara T; Oshiro H; Sakuma Y; Sata N; Niki T; Fukushima N
Pathol Int; 2019 Feb; 69(2):86-93. PubMed ID: 30729623
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814).
Park Y; Kim TH; Kim K; Yu JI; Jung W; Seong J; Kim WC; Choi JH; Chang AR; Jeong BK; Kim BH; Kim TG; Kim JH; Park HJ; Shin HS; Im JH; Chie EK
Cancer Res Treat; 2024 Jan; 56(1):272-279. PubMed ID: 37536713
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy.
Gwak HK; Kim WC; Kim HJ; Park JH
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):194-8. PubMed ID: 19910130
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.
Lim YJ; Koh J; Kim K; Chie EK; Kim S; Lee KB; Jang JY; Kim SW; Oh DY; Bang YJ
Target Oncol; 2017 Apr; 12(2):211-218. PubMed ID: 28084572
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer.
Lee HS; Lee SH; Roh YH; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Chemotherapy; 2016; 61(3):152-8. PubMed ID: 26788726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
